Trial intelligence / Profile preview

Tranexamic acid for prevention of postpartum hemorrhage at elective cesarean section

ACTRN12612000313831Phase 3Completed

Sponsor
Assiut University
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Assiut University. Primary endpoint: Mean blood loss. Started Aug 2011; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on ACTRN12612000313831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000313831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call